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2 elevated nitric oxide concentrations both within the cell and in the local environment. Cells deficient in DDAH2 were unable to mount this response.
Short Title
DDAH2 regulates immune cell nitric oxide synthesis in acute hypoxia. 
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1.Introduction
Hypoxia is a cardinal feature of critical illness of many aetiologies 1 It arises as a consequence of both increased metabolic demand 2 and also changes in the microcirculation that impair delivery of oxygen to the tissues 3 . Pro-and anti-inflammatory activation is also a major component of the response to critical illness 4, 5 . Mediated in large part by immune cells 6 , the interaction between hypoxia and monocytes has been shown to play a role in the immune response 7 and may give insights to the pathological responses seen in some patients in whom exaggerated systemic inflammation leads to organ failure and death.
Nitric oxide (NO) is an important regulator of a broad range of physiological processes 8 . In addition, it plays an important role in the response to infection [9] [10] [11] [12] . NO synthesised in response to infection has diverse functions including bactericidal and phagocytic function by monocytes 13 and the regulation of the macro 14 and microcirculation 15, 16 . The interaction between nitric oxide signalling and hypoxia is critically important in regulating the immune response to infection 17 .
Synthesised by the two constitutive and one inducible isoforms of nitric oxide synthase (NOS) 18 , NO production is regulated in part by the methylarginines asymmetric dimethylarginine (ADMA) and Monomethyl-L-arginine (L-NMMA) 19 .
Methylarginines are produced by post translational methylation of certain arginine residues in proteins by the family of Protein Arginine Methyltransferases (PRMTs). In mammals there are three methylarginine species, ADMA, symmetrical dimethyarginine (SDMA) and L-NMMA. ADMA and L-NMMA competitively inhibit arginine binding to NOS and reduce NO production 20, 21 . SDMA does not inhibit the activity of the NOS enzymes 22 . Elevated circulating concentrations of ADMA have been associated with poor outcomes in a variety of conditions including cardiovascular disease 23, 24 , metabolic disorders 25 and sepsis 26 .
ADMA is metabolised by dimethylarginine dimethylaminohydrolase (DDAH) to dimethylamine and citrulline 27 . The two isoforms of DDAH have different tissue distributions 27, 28 which lead to differing roles in both basal and pathological states. DDAH1 knockout or pharmacological inhibition leads to a hypertensive phenotype 29 and is protective in animal models of septic shock 30 whereas knockout of DDAH2 leads to minimal cardiovascular disturbance but profound immune dysfunction and excess mortality in sepsis 31 .
Recently we have demonstrated that in pulmonary endothelial cells hypoxia induces miRNAmediated reduction in DDAH1 expression that results in increased ADMA concentration and reduced nitric oxide synthesis that is associated with pulmonary hypertension 32 . The role of DDAH2 -the only isoform found in immune cells -in regulating the synthesis of NO in response to acute hypoxia has not been elucidated. Here we examine for the first time the impact of normobaric hypoxia on NO synthesis, ADMA level and DDAH2 expression in murine models and human healthy volunteers. Our data provide novel insights into the pathways by which hypoxia regulates NO synthesis following acute hypoxic stress.
Materials and Methods

Animal Models
Husbandry
Animals were housed in accordance with Home Office guidelines and procedures were performed under Project Licence (70/7049) and Personal License (76/26000). Throughout the care and M A N U S C R I P T
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experimental phases animals were kept in standard environmental conditions with free access to food and water.
Development of Genetically modified animals
DDAH2
flox/flox LysMCre animals employed the LoxP Cre recombinase model with tissue specificity delivered via Cre expression at the Murine M Lysozyme promoter using a previously established technique 33 . We have previously shown that immune cells express only DDAH2 but not DDAH1 28, 31 . See supplementary material for further details.
Isolation of resident peritoneal macrophages
Isolation of primary macrophages was undertaken using a peritoneal washout technique. Further details can be found in the supplementary materials.
Hypoxic Chamber incubation
To determine the impact of subacute hypoxia on isolated primary macrophages Cells were incubated for varied amounts of time in a sealed hypoxic incubator at 92% nitrogen, 3% oxygen and 5% CO 2 at 37°C. Culture medium (High Glucose DMEM with Glutamine) was placed in the chamber at least 12 hours prior to experiment in order to equilibrate medium partial pressure of oxygen with that of the hypoxic atmosphere. 
Normobaric Hypoxia
In order to study the relationship between acute hypoxia and methylarginine regulation, a healthy volunteer study was designed that explored the effect of moderate normobaric hypoxia on plasma methylarginine concentrations, monocyte DDAH2 expression and indices of haemodynamic function. In brief, healthy male volunteers aged between 18 and 60 were recruited and consent obtained. Following baseline haemodynamic and clinical observations, patients underwent phlebotomy and samples of blood were taken for plasma separation and isolation of peripheral blood mononuclear cells (PBMCs). Cardiovascular assessment was undertaken before entry to the hypoxic chamber.
Participants then underwent an 8 hour exposure to 12.0% oxygen in a hypoxic chamber with continuous observation of patient and environmental conditions. At 20 minutes after chamber entry and after each successive hour of hypoxic exposure, volunteers underwent haemodynamic and oxygenation assessments and completed a Lake Louise acute mountain sickness assessment modified to exclude the sleep assessment. This ensured that features of acute mountain sickness could be detected early and participants removed from the hypoxic chamber in this eventuality. Details of the hypoxic chamber, monitoring and safety can be found in the supplementary materials.
Following completion of the eight hour exposure period, participants underwent a repeat cycle of testing including blood sampling, observations and cardiovascular assessment. Samples from both the pre and post exposure phases were prepared and stored immediately upon collection at -80°C.
Isolation of peripheral blood mononuclear cells
Blood collected from the patient was diluted with twice the volume of balanced salt solution and layered carefully over an equal volume of Ficoll-Paque Premium (GE Life Sciences, UK) separation medium to avoid mixing of the two liquids.
The sample was centrifuged at 400g at 18-20°C for 40mins in a swinging bucket centrifuge without break to facilitate separation of the sample into plasma/platelets, monocyte and erythrocyte/granulocyte layers Following separation, the plasma portion of the separated blood was removed using manual pipetting and stored for later analysis. The mononuclear cell layer was removed without disruption of the Ficoll Medium and resuspended in RLT buffer for subsequent mRNA analysis or phosphate buffered saline with protease inhibitor for protein quantification and western blotting
Plasma sample preparation for analysis
Whole blood was collected in EDTA at 1.5mg/ml for analysis and stored on ice for subsequent preparation. Within 60mins of collection, the cells were removed from plasma by centrifugation for 10 minutes at 1,000-2,000g. Centrifugation for 15 minutes at 2,000g depletes platelets in the plasma sample. The separated plasma was stored separately at -80 °C pending subsequent analysis.
Sample preparation and analysis
Measurement of nitric oxide concentration in biological tissues:
The Sievers NOA 280i (GE Analytical Instruments) was used to measure nitrate + nitrite (NOx) content of biological samples using a chemiluminescent technique. Further details can be found in the supplementary materials. Nitric oxide was re-derived from nitrites and nitrates (stable end-products of NO activity) by reduction in heated vanadium chloride. NO was detected and quantified in a gas-phase chemiluminescent reaction with ozone which emits in the red/infra-red spectrum. Tissue homogenate or plasma samples underwent protein extraction using methanol precipitation. The supernatant from the samples were run in triplicate, averaged and NO quantified by calculation against a standard curve of sodium nitrate (0-200μM).
Preparation of samples for Mass Spectrometric analysis
Deuterium
7 labelled ADMA was used as an internal labelled control. A 50µL sample of supernatant from cell lysis or conditioned medium was collected and a known concentration of labelled deuterium standard was added. Following protein extraction with methanol the solution underwent centrifugation at 16000g for 10minutes. The sample was then dried and the residue re-suspended in mobile phase (0.1% formic acid) for analysis. A standard curve of ADMA samples of 10 known concentrations was prepared (0 to 100μM).
Statistics
Statistical analysis was performed using the Prism software package (GraphPad Inc, CA, USA). Normally distributed data was analysed using a t test or Analysis of Variance (ANOVA) with Bonferroni post-test comparison of groups as appropriate. Non parametric data was analysed using a Mann Whitney U test. In human studies, pre and post intervention samples are compared using paired analyses. All values were expressed as mean ± (SD). Significance was accepted for values of p < 0.05.
Results
Animal models of hypoxia
The synthesis of nitric oxide by isolated wild type primary murine monocytes exposed to hypoxic and normoxic conditions was determined. Intracellular nitrate plus nitrite concentration was higher in wild-type murine monocytes after hypoxia and reoxygenation than in normoxia-treated cells (mean(SD)) 13·2(2.4) pmols/mg protein vs 8·1(1·7) (p=0·009) (Fig 1A) , and accumulation of extracellular nitric oxide (Nitrate+Nitrite) increased after hypoxic challenge (13·7(3.1)µM vs 1·9(0·18), p=0·002) (Fig 1B) . This was associated with induction of the inducible form of nitric oxide synthase in monocytes, (mean (SD)) 4.0 (1.3) fold increase in iNOS mRNA (p=0.01) (Fig 1C) . DDAH2 protein was 4·5-fold (SD 1·3) higher than in control cells (p=0·03) (Fig 1D) and Ddah2 mRNA was also increased by (mean(SD)) 3.6(0.12) fold over control cells (Fig 1E) . This increase was associated with a 24% reduction in ADMA concentration (mean(SD) 0·33(0.04)pmols/mg to 0·24(0·03), p=0·002)( Fig  1F) . There was no significant difference observed in intracellular L-arginine (Fig S1A, p=0 .597) or L-NMMA (Fig S1B, p=0 .74) concentrations following hypoxic incubation. (Fig 2B) . This was associated with changes in intracellular ADMA in Ddah2 flox/flox mice; cells showed a similar decrease in ADMA concentration to that seen in wild type peritoneal macrophages (p=0.01) (Fig 2C) . In contrast to this, Ddah2
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MΦ-mice displayed a trend to increased ADMA level following hypoxia with concentrations of 0.13(0.04) µM/mg protein prior to exposure and of 0.28(0.03) µM/mg protein following hypoxic treatment (p=0.06) (Fig 2C) . No significant differences were observed in L-arginine (Fig 2D) or SDMA (Fig 2E) 
Human Hypoxia studies
Of fifteen participants, four exhibited subjective symptoms of acute mountain sickness with modified Lake Louise score of between 1 and 3 without significant objective symptoms. One volunteer developed significant nausea during the second half of the experimental period and was withdrawn from the hypoxic chamber. After a period of observation following extraction form the chamber there were no subjective or objective sequelae in this volunteer and follow up at 24 hours revealed no residual symptoms. The participant was excluded from the study and further analysis. Of the participants that completed the study, nine physiological, plasma and paired monocyte samples collection and analysis, a further three underwent plasma and physiological analysis only.
Hypoxic exposure in the fifteen participants led to an immediate reduction in arterial oxygenation to a mean(SD) value of 86(2.0)% which was sustained throughout the period of hypoxic chamber exposure (Fig 3A) . No significant differences in indices of cardiovascular function were detected by non-invasive assessment of cardiovascular function, although a trend towards reduced systemic vascular resistance with compensatory increase in cardiac output was observed in the post prandial period (Fig 3B-F) . Following completion of the hypoxia study protocol, participants were removed from the hypoxic chamber and arterial oxygen saturations assessed after 5mins of exposure to the normoxic environment. At this time, mean(SD) oxygen saturations were 97(1.0)% and heart rate was 71(10) bpm.
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Eight hour hypoxic exposure led to a significant increase in plasma NOx concentration (Mean (SD)) 3.6 (1.8)µM vs 6.4 (3.2)µM p=0.01 (Fig 4A) . This was associated with a significant reduction in plasma ADMA concentration from 0.42 (0.12)µM at baseline, to 0.29(0.05)µM after exposure (p<0.01) (Fig 4B) . There were no significant differences in plasma arginine, SDMA or L-NMMA concentration (Fig S2A-C respectively) . As a consequence of the reduction in ADMA concentration, plasma arginine:ADMA ratio was significantly reduced following hypoxia (p<0.01) (Fig 4C) . Intracellular concentrations of methylarginines in peripheral blood mononuclear cells (PBMC) displayed a similar pattern with significant reduction in ADMA in paired samples from 3·6 pmols/mg 
protein [0·27] to 3·15 [0·3] (p=0·0009) (Fig 4D) but no significant variation in intracellular arginine, SDMA or L-NMMA concentration (Fig S2D-F) . Similarly, the intracellular Arginine:ADMA ratio was reduced (p<0.01) (Fig 4E) . Consistent with previous observations of the relationship between plasma and monocyte ADMA concentrations 34 , at baseline there was no apparent correlation (r 2 =0.08, p=0.44) (Fig S2G) . However following hypoxia, a positive correlation between PBMC and extracellular ADMA level was observed (r 2 =0.72, p=0.01) (Fig 4F) . 
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In human subjects, the increase in NOx synthesis was not mediated by increased eNOS expression in PBMCs (Mean (SD)) change over baseline 0.68(0.28) fold (p=0.09) (Fig 5A) . There was no discernible iNOS mRNA and iNOS protein was not detectable in human PBMCs (data not shown). Reduction in monocyte ADMA was associated with an increase in DDAH2 mRNA expression (Mean (SD) increase of 1.9(0.6) fold over baseline (p=0.03) (Fig 5B) DDAH2 protein (Mean (SD) fold increase 2.5(0.94, p=0.034) (Fig 5C) .
Discussion
Inflammation either at the site of infection or systemically leads to an environment in which monocytes are exposed to grossly deranged conditions including hypoxia. It has been shown that acute hypoxia leads to delay in constitutive apoptosis in monocytes 35 . Hypoxia also has organism specific effects on bactericidal activity and the microenvironment itself 7 . The impact of acute hypoxic stress on regulators of NO synthesis by circulating immune cells has not been well elucidated and potentially has an impact both on immune cell function and also on the local microenvironment.
This study deepens our understanding of this process by exploring the impact of hypoxia on monocyte DDAH2 expression and regulation of NO synthesis. By using primary cells isolated from macrophage specific DDAH2 deficient mice and their relevant controls we have been able to elucidate the role this enzyme plays in regulating NO synthesis in hypoxia. Translating this work into humans has allowed us to demonstrate that this mechanism is preserved in humans following a clinically relevant degree of systemic hypoxia. It has previously been shown that in endothelial cells, DDAH2 is downregulated in Hypoxia. This suggests that DDAH2 regulation in hypoxia may be tissue specific and reflect differing adaptive responses to hypoxic stress. We have previously shown that global and macrophage specific knockout of DDAH2 in murine models of severe sepsis leads to a significant excess mortality which is mediated by impaired macrophage phagocytosis, bactericidal ability and NO synthesis 31 . Sepsis is a complex physiological insult in which multiple processes contribute to organ dysfunction and death. This study shows that a cardinal feature of critical illness -hypoxia -leads to a significant increase in monocyte NO synthesis mediated by an increase in DDAH2 expression that reduces ADMA concentrations and facilitates increased NOS activity. The mechanism of hypoxia mediated induction of DDAH2 requires further elucidation however recent work has shown that NRF2 induces DDAH2 expression 36 which in turn, has been shown to be induced by hypoxia 37 .
In macrophage specific knockout cells exposed to a hypoxic challenge, basal NOx is reduced and the increase in intracellular NOx seen in the floxed control cells upon exposure to hypoxia is not observed in the knockout cells. We postulate that this is one of the mechanisms by which animals deficient in DDAH2 demonstrate impaired monocyte function and elevated mortality in animal models of sepsis 31 and may in part explain the association between polymorphisms of the human DDAH2 gene and outcome in patients with septic shock 38 This study also highlights differing mechanisms in the synthesis of NO across species. In our murine studies, elevated iNOS was observed in isolated hypoxic primary murine macrophages consistent with previous studies of the impact of hypoxia on the inducible isoform of the enzyme 39 . By contrast, in the human samples, only a trend towards increased eNOS expression was observed. This is consistent with studies showing that in the absence of a pro inflammatory cytokine, iNOS induction is not observed in human hypoxia 40 . A number of studies have demonstrated previously that eNOS is present in human monocytes. There is limited evidence regarding the impact of hypoxia on immune cell eNOS expression, however a number of differing stimuli have been shown to regulate eNOS in isolated human monocytes 41 . Our data presented here suggest that regulation of eNOS activity in human macrophages by modulation of the concentration of competitive inhibitors contributes significantly to hypoxia-induced NO synthesis by these cells.
In summary, this study demonstrates that DDAH2 regulates ADMA mediated inhibition of NO synthesis in isolated murine primary monocytes and translates this observation into humans exposed to a clinically relevant model of normobaric hypoxia. We postulate that we have identified a novel mechanism, conserved between mice and humans that contributes to the monocyte response to hypoxia. It may also give insights into the mechanism by which polymorphisms in the human DDAH2 gene functionally impact NO synthesis and lead to clinically relevant outcomes in humans with septic shock.
Conclusions
• The regulation of nitric oxide synthesis by immune cells is a key component of the immune response to pathophysiological stress and regulates both cell function and the microenvironment • Here we show that acute hypoxia -a cardinal feature of pathological stress -leads to increased immune cell nitric oxide synthesis and that this is mediated by asymmetric dimethylarginine and the enzyme that metabolises it in monocytes, dimethylarginine Dimethylaminohydrolase 2.
• This translational study gives insights into the mechanism through which tissue hypoxia leads to local increases in nitric oxide level and offers avenues for further investigation of how this response may become pathological in some patients. • This translational study gives insights into the mechanism through which tissue hypoxia leads to local increases in nitric oxide level and offers avenues for further investigation of how this response may become pathological in some patients. Furthermore, DDAH2 modulation may possess therapeutic potential as a modulator of immune cell nitric oxide synthesis in response to pathological stress.
